✦ LIBER ✦

The effect of low-dose interleukin-2-based immunotherapy on salivary function and composition in patients with metastatic renal cell carcinoma

✍ Scribed by Rafael M. Nagler; Eliyahu Gez; Rafael Rubinov; Dov Laufer; Hanna Ben-Aryeh; Diana Gaitini; Margarita Filatov; Abraham Kuten

Book ID: 113988195
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 73 KB
Volume: 46
Category: Article
ISSN: 0003-9969
DOI: 10.1016/s0003-9969(01)00008-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose interleukin-2 immunotherapy is

High-dose interleukin-2 immunotherapy is safe for patients with metastatic renal cell carcinoma on dialysis

✍ JOHN P. BRUSKY; FAWEZ GAILANI; APURBA PATHAK; HATEL PATEL; SHERIF ABOSEIF 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

INTERLEUKIN-2 BASED IMMUNOTHERAPY FOR ME

INTERLEUKIN-2 BASED IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMA WITH THE KIDNEY IN PLACE

✍ WAGNER, JOSEPH R.; WALTHER, McCLELLAN M.; LINEHAN, W. MARSTON; WHITE, DONALD E.; 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 331 KB

Clinical outcome of combined immunothera

Clinical outcome of combined immunotherapy with interferon-α and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma

✍ Hideaki Miyake; Toshifumi Kurahashi; Atsushi Takenaka; Taka-aki Inoue; Masato Fu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Subcutaneous low-dose recombinant interl

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma

✍ Gaston, R; Oskam, R; Philip, T; Ravaud, A; Négrier, S; Cany, L; Merrouche, Y; Le 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 876 KB

CYTOREDUCTIVE SURGERY BEFORE HIGH DOSE I

CYTOREDUCTIVE SURGERY BEFORE HIGH DOSE INTERLEUKIN-2 BASED THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

✍ Walther, McClellan M.; Yang, James C.; Pass, Harvey I.; Linehan, W. Marston; Ros 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 499 KB

Long-term immunotherapy with low-dose in

Long-term immunotherapy with low-dose interleukin-2 and interferon-α in the treatment of patients with advanced renal cell carcinoma

✍ Carlo Buzio; Simeone Andrulli; Rosaria Santi; Laura Pavone; Rodolfo Passalacqua; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views